@article{ATM1612,
author = {Zhihua Feng},
title = {Minshan Chen: combination of TACE and RFA can improve the treatment of HCC},
journal = {Annals of Translational Medicine},
volume = {1},
number = {1},
year = {2013},
keywords = {},
abstract = {Transcatheter arterial chemoembolization (TACE) is the most widely used therapy for mid-stage hepatocellular carcinoma (HCC), while radiofrequency ablation (RFA) is commonly used as a therapy for early-stage HCC. This study combines RFA with TACE for the treatment of HCC. So where did this idea come from? Is there any plan for a follow-up research? },
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/1612}
}